Ovarian cancer vaccines are under development, but none are ready for primetime. There are no screening tools for ovarian ...

The 5-year OS rates were 46% in the HIPEC group versus 38% in the no-HIPEC group, they noted in Lancet Oncology. The trial ...

Buckhead’s Lenox Square Mall will host the 2024 Teal to Heal Fashion Show Thursday, Nov. 21, from 6:30 p.m. to 9 p.m., featuring ovarian cancer survivors and caregiver models st ...

British women who claim talcum powder gave them ovarian cancer are planning to take Johnson & Johnson to court, in the first ...

The EC has approved Elahere for treating adult patients with folate receptor-alpha (FRα) positive, platinum-resistant and ...

Nine years as an ovarian cancer “lifer” yields these tips for surviving and thriving when there’s no end of treatment ahead.

Haas added that J&J's own analysis found an absence of asbestos contamination in its products and said "independent science ...

Bianca Muñiz, a three-time cancer survivor first diagnosed at age 11, shared her powerful story on International Childhood ...

Thousands of women in the UK are planning to take legal action against Johnson & Johnson over alleged links between its baby ...

GlobalData market analysts predict that Elahere could generate up to $1.98bn in revenue for AbbVie by 2030. Credit: ...

A Derbyshire woman is among thousands of people planning a legal battle against one of the world's biggest pharmaceutical ...